MedPlus Health Services Limited (formerly known as MedPlus Health Services Private Limited)

Annexure: VIL
Notes to Restated Consolidated Financial Information
(All amounts are in Rs, in millions except as otherwise stated)
17, Share capital

Equity shares
Authorised shares (No's)

( Equity shares

As at beginning of the period year (465,000 (September 30, 2020: 215,000, March 31, 2021: 215,000, March 31, 2020: 215,000, March 31, 2019:
215,000) equity shares of Rs. 10/-each)

Increase during the period on account of split (1,860,000, (September 30, 2020: Nil, March 31, 2021: Nil, March 31, 2020: Nil, 31 March 2019:
Nil equity shares of Rs. 10/- each) equity shares of Rs. 2/- each)*

during the period year (29,908,000 (September 30, 2020: Nil, March 31, 2021: 250,000, March 31, 2020: Nil, 31 March 2019: Nil
equity shares of Rs. 10/- each) equity shares of Rs. 2/- each)

As at end of the period/ year (32,233,000, (September 30, 2020: 215,000, March 31, 2021: 465,000, March 31, 2020: 215,000, 31 March 2019:
215,000 equity shares of Rs. 10/- each) equity shares of Rs. 2/-each)

    

 

Incre

 

sat Asat

September September Mat Mach
Sosa“ aga00
16 ms
on 250
7s

Asat March As at March

31,2020 31,2019
215 215
2a5 245

*On July 23, 2021 the equity shares of the company having the face value of Rs.10 each were subelivided into 5 equity shares having face value of Rs.2 each. Accordingly 465,000, equity shares of face value of Rs.10

cach were subdivided! into 2,325,000 equity shares of face value of Rs.2 each

Preference shares of Rs.21/- each

 

As at beginning of the period / year (21,950,000 (September 30, 2020: 6,117,500, March 31, 2021: 6,117,500, March 31, 2020: 6,117,500), (March
31, 2019: 12,235,000 of Rs.10/- each) preference shares)

Increase during the period / year (Nil (September 30, 2020: Nil, March 31, 2021: 15,832,500, March 31, 2020: Nil, March 31, 2019: Nil)
preference shares)

As at endl of the period/ year (21,950,000 (September 30, 2020: 6,117,500, March 31, 2021: 1,950,000, March 31, 2020: 6,117,500, March 31,
2019: 6,117,500) preference shares of Rs.20/- each

Total Authorised share capital

Equity shares
Issued, subscribed and fully paid up shares (No's)

(Equity shares

32,202,130 equity shares of Rs.2/- each (‘September 30, 2020: 203,735, March 31, 2021: 458,409, March 31, 2020: 203,735,
208,635) equity shares of Rs.10/- each)

Less: amount recoverable from Medplus Employees Benefit Trust (ESOP Trust’) 10,420 (September 30, 2020: 9,673, March 31, 2021: 21,764
March 31, 2020: 9,673, March 31, 2019: 9,673 equity shares of Rs.10/- each) equity shares of Rs.2/- each , allotted to MedPlus Employees
Benefit Trust (eefer note no. 38 )

 

larch 31, 2019:

 

 

Compulsorily Convertible Preference Shares (CCPS')
Series A

2.836421 (September 30, 2020: 30,747, March 31, 2021: 2,836,421, March 31, 2020: 30,747, March 31, 2019: Nil) 0.001% Series A CCPS of
Rs.20/- each (refer Note 52 and 17(h))
Less: CCPS included under equity component of compound financial instrument (Refer Note 52)

Series B
8,956 480 (September 30, 2020: Nil, March 31, 2021: 11,951
each (refer Note 52 and 17(h))

   

(680, March 31, 2020: Nil, March 31, 2019: Nil) 0.001% Series B CCPS of Rs.20/-

Less: CCPS included under equity component of compound financial instrument (Refer Note 52)

Series BL
4,721,445 (September 30, 2020: Nil, March 31, 2021: 3,053,560, March 31, 2020: Nil, March 31, 2019: Nil) 0.001% Series BL CCPS of Rs.20/-
each (refer Note 52 and 17(h))

Less: CCPS included under equity component of compound financial instrument (Refer Note 52)

Series B2
1,676,418 (September 30, 2020: Nil, March 31, 2021: 3,331,120, March 31, 2020: Nil, March 31, 2019: Nil) 0.001% Series B2 CCPS of Rs.20/-
each (refer Note 52 and 17(h))

Less: CCPS included under equity component of compound financial instrument (Refer Note 52)

Series C1
360,896 (September 30, 2020: Nil, March 31, 2021: 560,896, March 31, 2020: Nil, March 31, 2019: Nil) 0.001% Series C1 CCPS of Rs.20/- each
(refer Note 52 and 17(h))

Less: CCPS included under equity component of compound financial instrument (Refer Note 52)

Series C2
160,147 (September 30, 2020: Nil, March 31, 2021: 160,147, March 31, 2020: Nil, March 31, 2019: Nil) 0.001% Series C2 CCPS of Rs.20/- each
(ofer Note 32 and 17(h))

Less: CCPS included under equity component of compound financial instrument (Refer Note 52)

Total issued, subscribed and fully paid up share capital

245

   

439.00 12.35 122.35
316.65
439.00 12.35 439.00

12450

6440 204 458
on) (0:10) @:10)
8 19 aa
56.72 ot 56.72
66.72) (061) 66.72)
179.13 : 230.03
79.13) - (239.03)
343 : 61.07
Gua) : (si.07)
33.53 : 66.62
353) : (66.62)
m2 : 12
(2 : (2)
320 ‘ 320

   

12.35 122.35

122.35 122.35

 

204 204
(0:10) (0:10)
194 19
ot s
(st) :

   
